0001209191-19-035630.txt : 20190607
0001209191-19-035630.hdr.sgml : 20190607
20190607174947
ACCESSION NUMBER: 0001209191-19-035630
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190606
FILED AS OF DATE: 20190607
DATE AS OF CHANGE: 20190607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brinkley David L
CENTRAL INDEX KEY: 0001302445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35952
FILM NUMBER: 19887053
MAIL ADDRESS:
STREET 1: 901 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383826477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
BUSINESS PHONE: 913.353.1000
MAIL ADDRESS:
STREET 1: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-06
0
0001509190
ARATANA THERAPEUTICS, INC.
PETX
0001302445
Brinkley David L
C/O ARATANA THERAPEUTICS, INC.
11400 TOMAHAWK CREEK PARKWAY, SUITE 340
LEAWOOD
KS
66211
1
0
0
0
Common Stock
2019-06-06
4
A
0
4500
0.00
A
18000
D
Stock Option (Right to Buy)
4.80
2019-06-06
4
A
0
7500
0.00
A
2029-06-05
Common Stock
7500
7500
D
Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date.
The transactions reported in this Form 4 consist of annual equity awards issued pursuant to the Issuer's Non-Employee Director Compensation Program, filed as Exhibit 10.2 to the Issuer's Form 10-Q dated August 5, 2016.
/s/ John C. Ayres, Attorney-in-Fact for David L. Brinkley
2019-06-07